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Minnesota Academic Health Center, Minneapolis, MinnesotaABSTRACT Cardiac troponin I (cTnI) functions as the molecular switch of the thin filament. Studies have shown that a histidine
button engineered into cTnI (cTnI A164H) specifically enhances inotropic function in the context of numerous pathophysiological
challenges. To gain mechanistic insight into the basis of this finding, we analyzed histidine ionization states in vitro by studying
the myofilament biophysics of amino acid substitutions that act as constitutive chemical mimetics of altered histidine ionization.
We also assessed the role of histidine-modified cTnI in silico by means of molecular dynamics simulations. A functional in vitro
analysis of myocytes at baseline (pH 7.4) indicated similar cellular contractile function and myofilament calcium sensitivity
between myocytes expressing wild-type (WT) cTnI and cTnI A164H, whereas the A164R variant showed increased myofilament
calcium sensitivity. Under acidic conditions, compared with WT myocytes, the myocytes expressing cTnI A164H maintained
a contractile performance similar to that observed for the constitutively protonated cTnI A164R variant. Molecular dynamics
simulations showed similar intermolecular atomic contacts between the WT and the deprotonated cTnI A164H variant. In
contrast, simulations of protonated cTnI A164H showed various potential structural configurations, one of which included
a salt bridge between His-164 of cTnI and Glu-19 of cTnC. This salt bridge was recapitulated in simulations of the cTnI
A164R variant. These data suggest that differential histidine ionization may be necessary for cTnI A164H to act as a molecular
sensor capable of modulating sarcomere performance in response to changes in the cytosolic milieu.INTRODUCTIONCardiac contraction and relaxation occur through cyclic
interactions of the thin and thick filaments of the sarcomere
(1). The key allosteric regulatory complex that mediates the
transition between the systolic and diastolic phases of the
cardiac cycle is troponin (2,3). Troponin is a heterotrimeric
protein complex that comprises three subunits: the tropomy-
osin-binding subunit, troponin T (TnT); the calcium-binding
subunit, troponin C (TnC); and the actomyosin ATPase
inhibitory subunit, troponin I (TnI) (4,5). After excitation
of cardiac muscle, calcium release from the sarcoplasmic
reticulum binds to the N-terminal region of TnC. Allosteric
changes in cardiac TnC (cTnC) cause the switch arm of TnI
to develop an affinity for TnC measured as an increase of
two orders of magnitude (6). This increased affinity causes
a translocation of the entire regulatory arm of TnI (residues
138–210) and binding of TnI with the N-terminal hydro-
phobic patch of TnC by multiple van der Waals contacts
(7,8). Binding of TnI to TnC during systole causes an allo-
steric opening of the hydrophobic patch of TnC (6). During
diastole, calcium is resequestered into the sarcoplasmic
reticulum, causing its dissociation from TnC. TnI subse-
quently releases TnC and binds actin at both the inhibitory
region and the C-terminal region (9–11). This initiates dias-Submitted July 20, 2011, and accepted for publication January 17, 2012.
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0006-3495/12/04/1570/10 $2.00tole by inhibiting actin-myosin cross-bridge formation.
With this important role of TnI differentially toggling
between actin and TnC, and thus regulating cross-bridge
cycling events, TnI has come to be known as the molecular
switch of the myofilament (12).
Studies using acutely isolated adult rat myocytes showed
that myofilament sensitivity to activating calcium (pCa) is
markedly diminished during acidosis (13). These reports
indicate that the pCa (log[Ca2þ]) required for 50% activa-
tion of myofilaments in acutely isolated adult cardiac myo-
cytes drops during acidification (from pH 7.0 to 6.2) (13).
These experiments illustrate that myofilament Ca2þ desensi-
tization at low pH is a fundamental molecular deficiency
that underlies, in part, myocyte and cardiac organ patholo-
gies associated with myocardial acidosis (14).
Recent studies showed that a unique histidine moiety in
the regulatory arm of TnI (slow skeletal TnI (ssTnI) H132
and cardiac TnI (cTnI) A164H) acts as a pH-dependent
titratable inotrope that is capable of ameliorating contractile
deficiencies caused by acidosis in vitro (13,15) and in vivo
(15–17) (Fig. 1). Here, a cognate histidine button, when
engineered into cTnI, functions as a molecular sensor with
no significant contractile effects at baseline but marked
enhancement of inotropic performance under various patho-
physiological stresses, including acute and chronic myocar-
dial ischemia and acidosis (15–18).
The histidine-button switch mechanism plays a critical
role in mediating several biological functions by altering
intra- and intermolecular structures and interactions. For
example, this molecular switch role for histidine is observeddoi: 10.1016/j.bpj.2012.01.024
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FIGURE 1 Primary amino-acid sequence of
cTnI A164H, WT cTnI, and ssTnI within the TnI
regulatory switch arm.
Imidazole Ionization of Histidine-Modified cTnI 1571in hemoglobin, where H146b mediates the Bohr effect by
altering its pH-dependent intramolecular interaction with
D94b (19,20). In addition to TnI and hemoglobin, numerous
other histidine buttons in biology have been identified,
including HLA-DR molecules (21), GABA r1 receptors
(22), the pacemaker channel HCN2 (H321) (23), the acid-
sensitive potassium channel TASK-3 (H98) (24), the inward
rectifying potassium channel HIR (H117) (25), and the
G-protein-coupled inward rectifying potassium channel
(GIRK1/GIRK4)(H64, H228, and H352) (26).
Histidine is unique among amino acids in that its chemi-
cal nature and pH-responsive binary ionization states enable
it to mediate the switch function of pH-responsive buttons in
the physiological pH range. The differential ionization of
histidine within the physiologic range is principally due to
its unique imidazole side chain, which has a pKa of ~6.0.
The nonprotonated histidine is hydrophobic and aromatic
in character, whereas the protonated histidine is hydrophilic
and positively charged.
The implications of a histidine modification for cTnI
structure and function are not well understood. Investigators
have employed numerous strategies involving site-directed
mutagenesis to analyze the molecular mechanism of histi-
dine buttons in other molecules (19–21,24,25).
In this work, our main goal was to gain mechanistic
insight into the function of cTnI. To that end, we analyzed
cellular contractile performance to understand the func-
tional implications of arginine (cTnI A164R) as a biochem-
ical mimic of the protonated histidine compared with the
contractile dynamics of wild-type (WT) cTnI (A164) and
cTnI A164H. To further elucidate the structural dynamics
of the His-164 moiety in cTnI, we used molecular dynamics
(MD) simulations to examine the structural dynamics in the
calcium-saturated cTn complex. This study provides the
first evidence, to our knowledge, that differential imidazole
side-chain ionization is the molecular basis for the titratable,
inotropic performance of histidine-modified cTnI.METHODS
cTnI in situ protein mutagenesis and viral vector
construction
We used a pDC315 adenoviral shuttle vector containing cTnI and the
QuikChange mutagenesis kit (Stratagene) to generate site-directed
mutagenesis. As previously described (15), the primers used for mutagen-
esis of cTnI to cTnIA164H FLAG removed an Xma1 site and were50- ggcactactggggacccggcacaaggaatccttggacctg-30 (sense) and 50-caggtccaa
ggattccttgtgccgggtccccagtagtgcc-30 (antisense). Mutagenesis of cTnI
A164R FLAG was generated from the cTnI A164H FLAG cDNA. Primers
used for mutagenesis from cTnI A164H FLAG to cTnI A164R FLAG were
50- gcactactggggacccggcgcaaggaatccttgg-30 (sense) and 50- ccaaggatt
ccttgcgccgggtccccagtagtgc -30 (antisense). In all cases, the primers were
extended with Pfu DNA polymerase, and methylated parental DNA was
subsequently digested with Dpn I. DNA was transformed into competent
bacterial cells. Mutated DNA with appropriate restriction enzyme sites
was sequenced before the mutant cTnI cDNA was ligated into Ad5 viral
shuttle vectors. All DNA sequences were verified by overlapping sequence
runs. The cTnI FLAG vector was produced and used as previously
described (27), and used here as a control for viral transduction and the
FLAG epitope. Recombinant vectors were produced and purified as
described previously (28).Ventricular myocyte isolation, gene transfer,
and primary culture
Adult rat ventricular myocytes were isolated as previously described
(17,29,30). Briefly, adult female rats were anesthetized by inhalation of iso-
flurane followed by i.p. injection of heparin (1500 U/kg) and Nembutal
(162.5 U/kg). Following enzymatic digestion by retrograde perfusion
with collagenase and hyaluronidase, and gentle mincing of the cardiac
ventricles, the cardiac myocytes were plated on laminin-coated glass cover-
slips (2104 myocytes/coverslip) and cultured in M199 media (Sigma, St.
Louis, MO) supplemented with 10 mmol/L glutathione, 26.2 mmol/L
sodium bicarbonate, 0.02% bovine serum albumin, and 50 U/ml peni-
cillin-streptomycin, with pH adjusted to 7.4, as described previously (31).
Recombinant adenovirus was applied to the cells immediately after plating,
as previously described (29). The cells were subsequently cultured for
4 days to provide sufficient time for stoichiometric replacement of TnI
proteins delivered by adenoviral gene transfer.Immunoblot detection
The myocytes were removed from coverslips and placed in Laemmli
sample buffer. Proteins were separated by SDS-PAGE and transferred to
a nitrocellulose membrane for immunodetection. After blocking in 5%
milk (in Tris-buffered saline), membranes were probed with a pan TnI anti-
body (MAB1691; Chemicon, Billerica, MA). Indirect immunodetection
was carried out using a fluorescently labeled secondary antibody (IRDye
680 conjugated affinity purified, 1:5000; Rockland, Gilbertsville, PA).
Western blot analysis was performed on an infrared imaging system
(Odyssey; Li-Cor, Milton, MA), and images were analyzed with Odyssey
software v. 1.2.Indirect detection of incorporation by
immunofluorescence and confocal microscopy
Dual-labeling immunofluorescence was performed as previously described
(12). Briefly, cultured cardiac myocytes were fixed in 3% paraformalde-
hyde/phosphate-buffered saline and blocked in 20% normal goat serum.
Myocytes were incubated in the first primary antibody directed againstBiophysical Journal 102(7) 1570–1579
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gated secondary antibody directed against mouse IgG (1:100; Molecular
Probes). Myocytes were incubated in the second primary antibody directed
against a-actinin (EA53, 1:500; Sigma) and detected with Texas Red-
conjugated secondary antibody directed against mouse IgG. All antibodies
were diluted in 2% normal goat serum þ 0.5% Triton X-100/phosphate-
buffered saline. Immunofluorescence was visualized on a Zeiss Axioskop
LSM 510 laser scanning confocal microscope.Contractility measurements in single
intact myocytes
Sarcomere length (SL) shortening and relaxation kinetics were performed as
previously described (17,29). Briefly, coverslips containing single isolated
myocytes were placed on an inverted microscope (Eclipse TE2000; Nikon)
and stimulated at 0.2 Hz. The chamber’s temperature was maintained at
37C. Myocyte images were collected (240 Hz) with a CCD camera (Myo-
Cam; IonOptix). Myocytes that did not follow the pacing protocol (0.2 Hz)
or had a resting SL of <1.70 mm were excluded. SL shortening and relaxa-
tion kinetics were calculated with the use of IonOptix software. Myocytes
were initially analyzed under baseline conditions in M199 (pH 7.4). To
elucidate the changes in myocyte performance during exposure to acidosis,
the same myocyte preparations were subsequently incubated with acidic
M199 (pH 6.2). In vivo NMR-based tracking of cardiac muscle intracellular
pH has shown we are working in the pH range found in ischemic hearts (15).
Other investigators (32) and we have used this pH differential to assess the
effects of acidosis on cellular biophysics. pH 7.4 mimics physiological pH,
whereas pH 6.2 mimics acidosis levels observed in the ischemic heart.
Because control (nontransduced) and cTnIFLAG-transduced myocytes
had no functional difference in sarcomere contractile kinetics, the data
were combined into the control dataset. The summary data for myocyte
contractile parameters are outlined in Table S1 of the Supporting Material.Skinned myocyte tension pCa measurements
Single rod-shaped cardiac myocytes were attached to micropipettes coated
in silicone adhesive and permeabilized in 0.2% Triton X-100 for 1 min. All
measurements were made at 15C in relaxation (RS) or activating solutions
(AS). Both RS and AS contained 1 mmol/L free Mg2þ, 4 mmol/L MgATP,
14.5 mmol/L creatine phosphate, 20 mmol/L imidazole, and potassium
chloride to yield an ionic strength of 180 mmol/L. Solution pH was adjusted
to 7.00 (or 6.20 for acidic pH experiments) with potassium hydroxide/
hydrochloric acid. The pCa (log[Ca2þ]) of the RS was 9.0, and the pCa
of maximal AS was 4.0. The SL was set to 2.1 mm and the isometric
tension-pCa relation was constructed by measuring the calcium-activated
isometric tension at basal (pCa ¼ 9.0), maximal (pCa ¼ 4.0), and various
submaximal calcium levels as previously described (15). Every third
contraction was taken at maximal pCa to normalize tension values. A
nonlinear least-squares fitting algorithm was used to determine the Hill
coefficient (n) and pCa50, the calcium concentration at which 50% of
maximal tension was produced. Because the control (nontransduced) and
cTnIFLAG genetically engineered myocytes showed no functional differ-
ence in steady-state isometric tension-Ca2þ relationship, the data were
combined into the control dataset. The summary data for myocyte tension
pCa analysis and Hill coefficients are outlined in Table S2.Molecular modeling
Molecular modeling was carried out with the use of the Schro¨dinger
(New York, NY) modeling suite package. The study was carried on the trun-
cated cTnI (residues 148–173): cTnC (residues 1–90) modeled complex
based on the x-ray crystallographic structures of the full-length human
cTnI (9) (PDB: 1J1E) complexed to Caþ2-bound TnC. The cTnI A164H
(residues 148–173)/cTnC (residues 1–90) and cTnI A164R (residues 148–Biophysical Journal 102(7) 1570–1579173)/cTnC (1–90) mutant complexes were generated by amino acid substi-
tution. The missing hydrogen atoms were added and energy-minimized
using the OPLS 2005 force field (33). The imidazole groups of all histidines
in the structure were ionized according to the calculated pKa values.MD simulation
All simulations were carried out using NAMD (29) version 2.6 with the
CHARMM27 protein force field (30) and TIP3P water model (34). Each
protein complex was solvated in a rectangular box with a 15 A˚water buffer
from the protein. Naþ and Cl counterions were added at 5 A˚ from the box
boundary to neutralize the total charge of the system. Each system was
initialized by a 5000-step conjugate gradient energy minimization with
protein heavy atoms restrained at 50 kcal/(mol $ A˚2). The restraint system
was gradually heated from 25 K to 300 K at 25 K increments at every 10 ps
interval for 100 ps, followed by a 100 ps equilibration with gradual removal
of the heavy atoms restraint at a 10 ps interval under the NVT condition.
The final unrestrained equilibration was carried out for 100 ps followed
by 40 ns of production simulation at 1 atm and 300 K under the NPT
condition. The simulations were carried out under the periodic boundary
condition using particle mesh Ewald (35). The SHAKE method (36) was
employed to restrain all hydrogen bonds. A 2 fs time step was used with
coordinates saved at 1 ps time intervals, resulting in a total of 40,000 config-
urations for simulation. Five 40-ns simulations were carried out for each of
the modeled complexes by random initialization of the starting velocities.Interatomic distance calculations
All distances were evaluated in angstrom units over the last 10 ns of the
simulation run for each of the simulated trajectories. For the cTnI
A164HSD and cTnI A164HSP simulations of the cTnI/cTnC complex, the
average distance was evaluated between cTnI H164 (NE2) and cTnC E19
(OE2). Distance measurements were also assessed between cTnI A164R
(NH2 or NH1) and cTnC E19 (OE2). Distance measurements for the WT
structure were taken between cTnI A164 (CB) and cTnC E19 (OE2).Root mean-square deviations
Ca residues root mean-square deviations (CaRMSDs) were evaluated using
the starting PDB structures as reference throughout each of the full 40-ns
simulations.Theoretical pKa calculations
The general continuum electrostatics method, which is widely used to
calculate the energetics of proton transfer and its corresponding pKa within
a consistent thermodynamic cycle, is described elsewhere (37,38). Here, the
calculations were carried out based on the web-based implementation of the
linearize Poisson-Boltzmann implicit solvent model (37) available via
Hþþ server (39) (http://biophysics.cs.vt.edu/Hþþ/). Briefly, the protein
pKa of ionizable residue, pK
p
a , is evaluated by
pKpa ¼ pKinta þ DpKchargesa ; (1)
where pKinta is the intrinsic pKa of the ionizable residue inside the protein
when all other ionizable groups are in their neutral states, and DpKchargesa
represents pKa shifts due to the charge-charge interaction between the
indicated titratable group and all other ionized groups in their average
ionization states in the protein. This method allows for a straightforward
decomposition of the total computed pKa value as the sum of the effects
due to the change in moving the ionized group from water to the polar envi-
ronment of the protein when all ionizable groups are set to their neutral state
ðpKinta Þ and its interaction with all other ionizable groups ðDpKchargesa Þ.
Thus, the calculated pKa values can be used to characterize the strength
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pKinta is evaluated as the change in the self-free energy of the indicated
ionizable group in its neutral (AH) and ionized (A) state from water to
the protein, DDGw/psolv and is given by
pKinta ðAHÞ¼ pKwa ðAHÞþ
1
2:303 RT
DDGw/pself

AH/A

(2)
Here pKwa is the model pKa of the amino-acid side chain in water. The elec-
trostatic contribution toward the changes in the self-free energy can be
described by
DDGw/pself ¼ DGpback þ DDGw/pborn (3)
where DGpback is the interaction between the ionized group with the protein
permanent dipoles, and DDGw/pborn is the free energy of desolvation of
moving the group from the water to the protein. We obtained the elec-
trostatic contribution to the self-free energy by evaluating the average
electrostatic potential based on the numerical solution to the linearized
Poisson-Boltzmann equation:
V $ εðrÞVfðrÞ  k2εðrÞfðrÞ ¼ 4pr0ðrÞ (4)
where ε(r) is the distance-dependent dielectric constant, f(r) is the electro-
static potential at point r, r0(r) is the permanent charge density of the
solute, and k is the inverse Debye-Hu¨ckel salt-screening length.
In this work, the protein was treated as a low-dielectric medium where
εin ¼ 40, and the surrounding solvent was assigned a high-dielectric
constant εout ¼ 80. The choice of a low protein dielectric constant for
pKa calculation was previously discussed (40), and higher dielectric
constants did not appreciably affect the predicted values obtained (Table
S3). The Debye-Hu¨ckel screening parameter k was used to set the electro-
static screening effects of the salt concentration corresponding to physio-
logical conditions of 0.145 M. The pKa values shown in Table 1 were
derived by calculating the intrinsic pKa (pKint), which corresponds to the
pKa of the group of interest wherein all of the other titratable amino acids
are maintained in the neutral state (38), and the pKa from two different
structures (20 ns and 40 ns) during the time-course of each simulation.Statistics
All results are expressed as the mean 5 standard error (SE). Multigroup
comparisons were assessed by one-way analysis of variance (ANOVA)
with the Newman-Keuls post-hoc test, with p< 0.05 considered statistically
different.RESULTS
Stoichiometric incorporation of TnI into myocytes
after adenoviral gene transfer
We used in vitro methods to address the role of ionization in
the molecular inotropic behavior of cTnI A164H. To accom-
plish this, we generated recombinant adenoviruses express-
ing various TnI proteins that act as chemical mimetics of
different histidine ionization states. These included WT
cTnI A164 (constitutively deprotonated mimetic), cTnI
A164R (constitutively protonated mimetic), and cTnI
A164H (pH-dependent ionization). Stoichiometric expres-
sion of exogenously delivered myofilament proteins causes
dose-dependent competitive replacement of endogenousproteins to achieve synchronous and efficient genetic modi-
fication of adult cardiac myocytes (13,15,17,29). In this
study, we delivered specific TnI variants by adenoviral
gene transfer to assess their functional effects on the perfor-
mance of TnI myofilaments in intact and permeabilized
myocytes. Beginning on day 1, stoichiometric replacement
of endogenous cTnI by AdTnI could be detected by Western
blot (Fig. 2 a). AdTnI stoichiometric replacement increased
progressively until day 4 after gene transfer, at which
point genetically modified myocytes showed, in all cases,
~80–90% replacement of endogenous cTnI. Laser scanning
confocal microscopy using indirect immunofluorescence
against the FLAG epitope showed uniform and precise
localization of exogenous TnI proteins in the thin filament
of the sarcomere (Fig. 2 b).Myocyte sarcomere function at baseline and
during exposure to acidosis
Dynamic SL-shortening and relaxation kinetics, as well as
the steady-state isometric tension-pCa relationship, were
analyzed 4 days after acute adenoviral-mediated gene trans-
fer into isolated single adult rat cardiac myocytes (Fig. 3 a,
Table S1, and Table S2). Measurements were taken under
baseline and acidic conditions. As a measure of contractility,
calcium-activated isometric tension (pCa50) and normalized
SL shortening were used as markers of cellular inotropic
performance in the context of WT and TnI-modified thin
filaments. Baseline analysis of SL shortening and pCa50
showed that WT and cTnI A164H-modified myofilaments
were not different compared with the heightened myofila-
ment calcium sensitivity and cellular contractility observed
in myocytes expressing the cTnI A164R variant (p < 0.05
versus WT and cTnI A164H; Fig. 3 b). When myocytes
were exposed to acidic conditions the contractile function
and pCa50 of cTnI A164H and cTnI A164R were not statis-
tically different compared with a significantly reduced
inotropic capacity and reduced myofilament calcium sensi-
tivity observed in WT myocytes (p < 0.05 versus cTnI
A164H and cTnI A164R; Fig. 3 c). The delta change from
baseline to acidosis was calculated to determine the net
change in inotropy attributable to reduced pH (Fig. 3 d).
These data showed that only cTnI A164H had pH-dependent
titratable inotropy, as indicated by the maintenance of con-
tractile function and improved calcium sensitivity of the
myofilaments during the pH shift compared with WT cTnI
and cTnI A164R. In contrast, WT cTnI and cTnI A164R
were equally affected by acidosis, as shown by a similar
decrease in normalized SL shortening and rightward shift
of the pCa50 during the pH change. These data are consistent
with the hypothesis that the arginine variant, which has a
basic R group, functions as a constitutive calcium sensitizer.
In contrast, alanine in the WT TnI is nontitratable, consis-
tent with the biochemistry of its methyl group. The histidine
substitution provides a substrate for differential ionizationBiophysical Journal 102(7) 1570–1579
TABLE 1 pKa calculations for MD simulations
cTnC, cTnI WT cTnC/cTnI A164R
pKinta DpK
charges
a pK
p
a pK
int
a DpK
charges
a pK
p
a
(εin ¼ 4) (εeff ¼ 40) (εin ¼ 4) (εeff ¼ 40)
cTnC cTnC
Asp-2 3.99 0.54 3.45 Asp-2 4.00 0.38 3.62
Asp-3 4.24 0.40 3.84 Asp-3 4.19 0.33 3.86
Tyr-5 12.97 0.29 13.26 Tyr-5 12.12 0.35 12.47
Lys-6 9.50 2.76 12.26 Lys-6 9.69 2.77 12.45
Glu-10 4.54 0.12 4.42 Glu-10 4.56 0.05 4.51
Glu-14 4.35 0.17 4.18 Glu-14 4.88 0.36 4.52
Glu-15 4.10 0.07 4.17 Glu-15 4.37 0.17 4.21
Lys-17 9.89 1.04 10.93 Lys-17 9.92 1.19 11.11
Glu-19 5.01 0.63 4.37 Glu-19 5.18 1.45 3.73
Lys-21 9.99 0.93 10.92 Lys-21 10.03 0.81 10.83
Asp-25 4.62 0.59 4.03 Asp-25 4.30 0.42 3.89
cTnI WT cTnI A164R
Arg-149 9.82 2.43 12.24 Arg-149 10.05 2.28 12.33
Asp-153 3.68 0.61 3.06 Asp-153 4.30 0.77 3.53
Arg-163 9.87 1.88 11.76 Arg-163 10.89 1.05 11.94
Arg-164 9.86 1.56 11.41
Lys-165 10.22 0.41 10.64 Lys-165 10.10 0.43 10.53
Glu-166 4.93 0.33 4.60 Glu-166 4.91 0.73 4.18
Asp-169 3.99 0.92 3.07 Asp-169 4.62 0.77 3.85
Arg-171 11.71 0.36 12.07 Arg-171 11.50 0.60 12.10
His-173 6.62 0.43 7.06 His-173 6.95 0.14 7.08
cTnC cTnC
Asp-2 3.87 0.29 3.57 Asp-2 3.93 0.46 3.59
Asp-3 4.05 0.22 3.83 Asp-3 4.27 0.48 3.74
Tyr-5 12.59 0.45 13.04 Tyr-5 12.60 0.57 13.36
Lys-6 9.70 3.26 12.96 Lys-6 9.78 2.28 11.85
Glu-10 4.66 0.28 4.39 Glu-10 4.61 0.13 4.48
Glu-14 5.67 1.18 4.48 Glu-14 4.80 0.47 4.38
Glu-15 4.35 0.19 4.16 Glu-15 4.25 0.03 4.27
Lys-17 9.85 1.96 11.81 Lys-17 10.02 1.23 11.38
Glu-19 4.16 1.25 2.92 Glu-19 4.54 0.13 4.42
Lys-21 9.93 0.62 10.54 Lys-21 10.16 0.77 10.91
Asp-25 4.58 0.55 4.03 Asp-25 4.49 0.67 3.86
cTnI A164H cTnI A164H
Arg-149 12.22 2.65 14.87 Arg-149 10.36 2.22 12.51
Asp-153 3.84 0.50 3.34 Asp-153 4.18 0.32 3.85
Arg-163 10.65 1.20 11.85 Arg-163 10.50 1.48 12.04
Hsp164 5.90 0.50 6.40 His164 6.52 0.14 6.46
Lys-165 10.07 1.03 11.10 Lys-165 10.11 0.41 10.52
Glu-166 4.42 0.31 4.11 Glu-166 5.33 0.84 4.44
Asp-169 4.53 1.55 2.98 Asp-169 4.65 0.90 3.82
Arg-171 11.28 0.76 12.04 Arg-171 11.79 0.34 12.19
His-173 6.44 0.44 6.88 His-173 6.74 0.21 6.95
Predicted protein pKa values for all ionizable residues as an average of the 20-ns and 40-ns structures for cTnI A164 (simulations 1–5), cTnI A164R
(simulations 1–4), cTnI A164HSP (simulation 5), and cTnI A164H (simulations 1–5).
1574 Palpant et al.due to the unique pKa of its imidazole moiety, which is de-
protonated under physiological pH but becomes protonated
under mildly acidic conditions. These data also indicate that
the histidine-substituted troponin modification of the
myofilaments alone cannot account entirely for the pH-
dependent titratable inotropy. The calcium sensitivity of
the myofilaments was affected by the pH change, albeit
not to the extent observed with WT cTnI and cTnI
A164R. This evident pH-dependent effect was not observed
in the intact myocytes, which in the cTnI A164H contextBiophysical Journal 102(7) 1570–1579retained baseline contractile performance at acidic pH.
Further experiments are required to determine the role of
calcium regulation or other potential modulators that may
be involved in regulating pH-responsive contractile perfor-
mance in cardiac myocytes.Simulation and pKa calculations
We performed an MD simulation of the calcium-saturated
state of the cTn complex (7) (PDB: 1j1e chains DEF) to
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FIGURE 3 SL shortening and tension pCa measurements under physio-
logic and acidic conditions. (a) Top: Raw traces illustrating the change in
SL-shortening kinetics between 7.4 and 6.2 for each group (horizontal
bar (time) ¼ 0.1 s; vertical bar (SL) ¼ 0.1 mm). Bottom: Normalized
tension-pCa50 curves illustrating the change in myofilament calcium sensi-
tivity (pCa50) between 7.0 and 6.2 for each group (horizontal bar (pCa50) ¼
1 U). (b) Mean values of percent SL peak height and myofilament pCa50 at
baseline. (c) Mean values of percent SL peak height and myofilament pCa50
during exposure to acidosis. (d) Mean values showing the d change from
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peak height and (right) myofilament pCa50. For all groups, n> 50 myocytes
from more than three independent myocyte preparations. * p < 0.05
compared with all other groups by one-way ANOVA.
Imidazole Ionization of Histidine-Modified cTnI 1575gain atomistic insight into the effects of a histidine substitu-
tion in cTnI on the intermolecular engagement between
cTnI and cTnC. To that end, we performed in silico struc-
tural truncation (cTnI (residues 148–173)/cTnC (residues
1–90)) followed by protein mutagenesis (cTnI A164H and
cTnI A164R; Fig. 4 a).
To assess the effects of the differential ionization states of
histidine, we complexed WT cTnC with various TnI struc-
tures, including WT cTnI and cTnI A164H (with its imid-
azole group either deprotonated (cTnI A164HSD) or
protonated (cTnI A164HSP)). Similar to in vitro biophysical
assays, cTnI A164R was also simulated to determine the
effects of a biochemical mimic of protonated cTnI
A164H. Atomistic insights into these structural differences
were acquired during five independent 40-nsMD simulations
of the cTnI/cTnC regulatory engagement in the calcium-
saturated state (Movie S1 (simulation 1 for WT cTnI/
cTnC), Movie S2 (simulation 1 for cTnI A164HSD/cTnC),
Movie S3 (simulation 5 for cTnI A164HSP/cTnC), and
Movie S4 (simulation 1 for cTnI A164R/cTnC). Instead of
performing a single continuous MD simulation, we carriedout multiple short simulations with different starting veloci-
ties to assess the potential conformation spaces accessible by
the various troponin structures.
To assess the importance of an electrostatic intermolec-
ular contact between position 164 of cTnI and cTnC E19,
we obtained interatomic distance measurements across the
40 ns of each structure’s MD simulation (Fig. 4, b). These
data showed no evidence of engagement between cTnCBiophysical Journal 102(7) 1570–1579
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FIGURE 4 MD simulations of the
calcium-saturated cTn complex. (a)
Truncation of the raw crystal structure
as reported by Takeda et al. (7) with
cTnC residues 1–90 (red), and
cTnI residues 148–173 (blue) used as
the starting structure (t ¼ 0) for all
simulations. The yellow moiety
indicates position 164 of cTnI. (b)
Interatomic distance measurements
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A164HSD (NE2), cTnI A164HSP
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(c) Structure of cTnI A164HSP simula-
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chains of cTnC E19 and cTnIH164.
(d) Root mean-square deviation
(RMSD) analysis of cTnIA164HSP
and cTnIA164R simulations 1–5. (e)
Average RMSD for each simulation.
*p < 0.05 by one-way ANOVA.
1576 Palpant et al.E19 and position 164 of WT cTnI (sim 1–5) or cTnI
A164HSD (sim 1–5). MD simulations for cTnI A164HSP
(sim 1–4) also did not come close enough for salt-bridge
formation (Fig. 4 b). In contrast, cTnIA164HSP (sim 5)
showed structural shifts of helix 4, indicating sustained elec-
trostatic engagement between cTnI H164 and cTnC E19
(Fig. 4, b and c). Simulations of cTnI A164R, the biochem-
ical correlate of the protonated histidine, showed an even
higher probability of salt-bridge formation with cTnC E19
(Fig. 4 b). Four out of five MD simulations showed sus-
tained interaction between these two amino acids
throughout the experiment. Extraction of a structural snap-
shot during the MD simulation of the cTnI A164HSP com-
plexed with cTnC shows that cTnI H164 and cTnC E19
interacted to form a salt bridge by hydrogen-bonding at
a distance of <3 A˚ (Fig. 4 c).
Root mean-square deviation (RMSD) analysis of all of
the cTnIA164HSP MD simulations showed that simulation
5 had the lowest deviation from the starting structure (Fig. 4,
d and e). Beyond the stability of single atomic interactions,
these data show evidence of thermodynamic stability across
the entire cTnI structure caused, at least in part, by the elec-
trostatic interaction between cTnC E19 and cTnI H164 in
the calcium-saturated state. Similarly, structural analysis
of the cTnI A164R variant showed that all simulations in
which R164 developed a salt bridge with cTnC E19 (simu-
lations 1, 3, 4, and 5) and showed significantly lower
RMSDs than the single simulation that failed to form this
bond (simulation 2).Biophysical Journal 102(7) 1570–1579Additionally, theoretical side-chain pKa calculations, aver-
aged from multiple simulated structures, showed a marked
pKpa shift for residues cTnC E19 and cTnI 164 of the
A164HSP and A164R structures, consistent with formation
of a salt bridge (Table 1). Examination of the A164 and
A164H deprotonated simulated structural complexes indi-
cated that residues cTnC E19 and A164H underwent no
observable shifts and thus remained solvent-exposed (Table1).
On the basis of the MD simulation data, a positive charge
at cTnI position 164 (either arginine or protonation of histi-
dine’s imidazole group) suggests a structural configuration
involving a key interaction with cTnC Glu-19. In a compar-
ison of simulated structures, no other major differences were
observed in terms of number of intermolecular contacts,
average probability of intermolecular atomic interactions,
binding energies, and other variables that could account
for structure-function correlations due to the histidine
substitution (data not shown). Among the variables as-
sessed, the electrostatic interaction between cTnI position
164 (A164HSP or A164R) and cTnC E19 appears to be
a unique modifier of structural behavior. Supporting in vitro
biophysical assays presented in this study, these data point
to a potential mechanism whereby cTnI A164H can main-
tain inotropy during acidosis.DISCUSSION
This study provides important insight into the molecular
mechanism underlying the pH-responsive titratable
Imidazole Ionization of Histidine-Modified cTnI 1577molecular inotropy observed with a single histidine modi-
fied cTnI (A164H). Previous reports revealed that a histidine
button engineered into the regulatory domain of cTnI
provides a substrate for therapeutically modulating cardiac
performance in response to various pathophysiological
stresses (15–17). However, the molecular mechanism for
this phenotype has not been elucidated. In this study, we
used in vitro functional analysis and in silico MD simula-
tions to gain insight into the role of differential imidazole
ionization in regulating the unique function of histidine-
modified cTnI. Theoretical side-chain pKa calculations,
averaged from multiple MD simulated structures, provide
evidence that the ionization of the imidazole moiety in
cTnI A164H is governed primarily by changes in solvent
pH, and not by intermolecular electrostatic interactions.
Under neutral pH conditions, cTnI A164H has in vitro
biophysical properties comparable to those of WT cTnI.
Similarly, bothWTand cTnI A164H have markedly reduced
pCa50 and myocyte contractility compared with the consti-
tutively protonated calcium sensitizer cTnI A164R. These
data suggest that cTnI A164H remains deprotonated under
physiological conditions. Structural simulations further
support the hypothesis that deprotonated histidine in cTnI
A164H behaves similarly to WT cTnI when complexed
with cTnC.
Under acidic conditions, cTnI A164H has in vitro
biophysical characteristics of heightened pCa50, and
enhanced contractility similar to that of the calcium sensi-
tizer cTnI A164R, the biochemical correlate to a protonated
imidazole. This is supported by MD simulations showing
that a single proton added to histidine in cTnI A164H
may provide a substrate for an electrostatic interaction
between H164 of cTnI and E19 of cTnC. However, struc-
tural variability is evident in the cTnI A164HSP simula-
tions, suggesting multiple potential structural variations
that could give rise to the functional characteristics of
cTnI A164H. Structural simulations of cTnI A164R show
four of five independent simulations forming a salt bridge
between cTnI R164 and cTnC E19. This supports the
hypothesis that an electrostatic interaction is structurally
favorable within the potential conformational spaces of
these proteins when a positive charge is present at cTnI posi-
tion 164. Together, the in vitro and in silico data support the
hypothesis that differential imidazole ionization of histidine
enables cTnI A164H to act as a molecular sensor capable of
regulating sarcomere function in response to acute and
chronic changes to the intracellular biochemical milieu.
Westfall et al. (41) assessed the calcium sensitivity of
cardiac myofilaments using chimeric TnI molecules to
show a role for the C-terminal region of cTnI in regulating
cardiac contractility. Furthermore, Fo¨rster resonance energy
transfer experiments revealed that movements of the regula-
tory arm of TnI during systole and diastole are essential for
transmitting the calcium signal to the rest of the myofila-
ment proteins (42,43). As a basis for this observation, Liet al. (6) used multinuclear, multidimensional NMR spec-
troscopy to show that side-chain contacts between the
switch peptide of cTnI (residues 147–163) engage the
calcium-saturated N-terminal region of cTnC through
multiple hydrophobic interactions. This observation was
supported by a crystal structure analysis of the calcium-satu-
rated cTn core complex (7). These hydrophobic side-chain
contacts were similarly observed in regulatory interactions
within the fast skeletal (fs) troponin structure (44).
Gene-transfer and transgenic studies showed that alter-
ations in the peptide composition of the TnI switch arm
can markedly alter myofilament performance (15,45–47).
Studies with TnI isoform chimeras showed a unique role
for the C-terminal domain of ssTnI in modulating myofila-
ment function in response to changes in pH (41,48). Further
peptide modifications show a histidine residue in the switch
arm as a keymoiety responsible for modulating performance
in cTnI (cTnI A164H) (15,46). Site directed mutagenesis
studies provide evidence that a single histidine to alanine
substitution in the switch arm of ssTnI (H132A) causes
markedly increased pH sensitivity and a significant diminu-
tion in inotropy analogous to WT cTnI (45). Our analysis
of the crystal structure of a closely related TnI, fsTnI (44),
suggests that H132 engages closely with cTnC E19 in the
calcium-saturated state (18). Using MD simulations, we
found that an alanine substitution breaks this close intermo-
lecular electrostatic interaction, which is required for height-
ened inotropy, and eliminates the substrate for pH-responsive
histidine ionization, which is necessary for the titratable
contractile performance observed with ssTnI (18). Recent
findings (18) suggest that cTnC Glu-19 is a critical acidic
residue that engages with His-130 of ssTnI (which structur-
ally corresponds to position 164 of cTnI). This electrostatic
salt bridge between ssTnI H132 and cTnC E19 appears to
be essential for the majority of the binding energy (DDG)
between these proteins in the calcium-saturated state. In an
evolutionary sense, these data suggest that this key residue
modification of H132A reduced myofilament calcium
sensitivity by making cTnI molecularly untethered from
cTnC. We recently proposed that, to meet the demands for
refined performance of the mammalian adult heart, compen-
satory evolutionary pressures favored amino-acid mutations
that enhanced the relaxation properties of cTn by decreasing
its sensitivity to activating calcium (18). Taking evolution
in the reverse direction, the reciprocal substitution in the
contemporary milieu of the mammalian cTnI (cTnI
A164H) was shown to provide a means of reintroducing
pH-responsive titratable contractile performance without
enhanced inotropy at baseline (15,16).
This study provides important evidence that histidine
imidazole ionization is the primary mechanism for the
pH-responsive titratable inotropy observed with cTnI
A164H. Under neutral pH conditions, WT cTnI and cTnI
A164H behave similarly, based on myofilament sensitivity
to pCa and SL-shortening kinetics. The calculated pKa ofBiophysical Journal 102(7) 1570–1579
1578 Palpant et al.H164 at 6.45 supports a two-state pH-dependent ionizable
switch mechanism. We hypothesize that the H164 side chain
remains primarily deprotonated under physiological condi-
tions at pH > 7, whereas under acidic conditions at pH < 7,
the propensity for H164 imidazole to become protonated
will greatly increase. Compared with A164H, the hypercon-
tractility observed with constitutive protonation at residue
164 (cTnI A164R) at baseline supports this conclusion.
Thus, at physiological pH, WT cTnI and cTnI A164H
have similar molecular inotropic functions mediated by
structural dynamics largely involving intermolecular hydro-
phobic side-chain contacts with cTnC (6,7).
In contrast, under acidic conditions, measures of myofila-
ment sensitivity and SL-shortening dynamics indicate that
WT cTnI has significantly compromised inotropic function
compared with cTnI A164H and the cTnI A164R variant.
The calculated pKa of the A164H side chain indicates that
solvent effects onH164would support imidazole protonation
under acidic conditions. As such, the functional implications
of histidine ionization are corroborated byMDsimulations of
cTnIA164H/cTnC and cTnI A164R/cTnC. These simulation
data indicate that a protonated moiety in cTnI at position 164
enables cTnI to engage in a more thermodynamically stable
conformation with cTnC in the calcium-saturated state,
mediated at least in part by an electrostatic contact occurring
between cTnI H164 and cTnC E19. Taking the structural,
cellular, and organ-level data together, we propose the
following model for the titratable inotropy observed with
cTnI A164H: solvent-mediated differential ionization of
histidine enables cTnI A164H to remain deprotonated at
baseline, resulting in inotropy similar to that observed for
WT cTnI. As the pH becomes increasingly acidic, proton-
ation of histidine’s imidazole group enables the maintenance
of baseline myofilament contractile performance, at least in
part through this thermodynamically favorable electrostatic
contact at the cTnC:cTnI interface.
Understanding the basis for the therapeutic implications
of a histidine button in cTnI provides important insights
into the mechanisms that modulate cardiac performance in
response to ischemia or acidosis. Using cTnI A164H as
a gene therapy vector, and identifying small molecules
that mimic the pH-responsive features of histidine-modified
cTnI may be a valuable approach for treating numerous
cardiomyopathies. Specifically, although this molecule has
little to no effect on contractile function at baseline, it
protects inotropic performance in response to acute or
chronic stresses such as myocardial ischemia. The evidence
presented here shows that imidazole ionization is necessary
for the pH-responsive titratable inotropy observed with
myofilaments containing histidine-modified cTnI.SUPPORTING MATERIAL
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